Literature DB >> 20004998

ATM polymorphisms and risk of lung cancer among never smokers.

Yen-Li Lo1, Chin-Fu Hsiao, Yuh-Shan Jou, Gee-Chen Chang, Ying-Huang Tsai, Wu-Chou Su, Yuh-Min Chen, Ming-Shyan Huang, Hui-Ling Chen, Pan-Chyr Yang, Chien-Jen Chen, Chao A Hsiung.   

Abstract

The ataxia-telangiectasia mutated (ATM) gene, an important caretaker of overall genome stability, is thought to play a role in the development of human malignancy. Therefore, we hypothesized that sequence variants in ATM may influence the disposition to lung cancer. In this hospital-based matched case-control study, nine ATM single nucleotide polymorphisms (rs189037, rs228597, rs228592, rs664677, rs609261, rs599558, rs609429, rs227062, and rs664982) were genotyped in 730 lung cancer patients and 730 healthy controls. Pairwise linkage disequilibrium among nine polymorphisms in the ATM gene was very high. None of the main effects of any of the ATM polymorphisms were related to the risk of lung cancer. Interestingly, ATM polymorphisms were significantly associated with lung cancer among never smokers, and the association was modulated by low-level exposure to carcinogens such as environmental tobacco smoke. When the haplotypes of nine ATM polymorphism sites were studied, no overall association between ATM haplotypes and risk of lung cancer was found. However, the frequency distribution of haplotypes between lung cancer cases and controls was significant in the never smokers (P=0.009), demonstrating that haplotypes have a significant effect on the risk of lung cancer. In conclusion, we found that never smokers with sequence variants of the ATM gene may be at increased risk for lung cancer. Our data also suggest this association may be further modified by exposure to environmental tobacco smoke. This study suggests support to the literature that ATM polymorphisms and environmental tobacco smoke exposure have a role in lung carcinogenesis among never smokers. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20004998     DOI: 10.1016/j.lungcan.2009.11.007

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  23 in total

1.  A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors.

Authors:  Arun Rajan; Corey A Carter; Ronan J Kelly; Martin Gutierrez; Shivaani Kummar; Eva Szabo; Mary Ann Yancey; Jiuping Ji; Baskar Mannargudi; Sukyung Woo; Shawn Spencer; William Douglas Figg; Giuseppe Giaccone
Journal:  Clin Cancer Res       Date:  2012-02-27       Impact factor: 12.531

2.  Germline Mutations in DNA Repair Genes in Lung Adenocarcinoma.

Authors:  Erin M Parry; Dustin L Gable; Susan E Stanley; Sara E Khalil; Valentin Antonescu; Liliana Florea; Mary Armanios
Journal:  J Thorac Oncol       Date:  2017-08-24       Impact factor: 15.609

3.  Association between ATM polymorphisms and cancer risk: a meta-analysis.

Authors:  Li Shen; Zhi-Hua Yin; Yan Wan; Yue Zhang; Kun Li; Bao-Sen Zhou
Journal:  Mol Biol Rep       Date:  2011-12-28       Impact factor: 2.316

4.  Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.

Authors:  Sasinya N Scott; Irina Ostrovnaya; Caroline M Lin; Nancy Bouvier; Bernard H Bochner; Gopakumar Iyer; David Solit; Michael F Berger; Oscar Lin
Journal:  Cancer Cytopathol       Date:  2017-03-24       Impact factor: 5.284

5.  Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO.

Authors:  Trevor L Hoffman; Hilary Kershberg; John Goff; Kimberly J Holmquist; Reina Haque; Monica Alvarado
Journal:  Fam Cancer       Date:  2022-10-20       Impact factor: 2.446

6.  A NOVEL AND EFFICIENT ALGORITHM FOR DE NOVO DISCOVERY OF MUTATED DRIVER PATHWAYS IN CANCER.

Authors:  Binghui Liu; Chong Wu; Xiaotong Shen; Wei Pan
Journal:  Ann Appl Stat       Date:  2017-10-05       Impact factor: 2.083

7.  The association between ATM IVS 22-77 T>C and cancer risk: a meta-analysis.

Authors:  Lin Zhao; Aihua Gu; Guixiang Ji; Peng Zou; Peng Zhao; Ailin Lu
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

Review 8.  Against Lung Cancer Cells: To Be, or Not to Be, That Is the Problem.

Authors:  Naoko Okumura; Hitomi Yoshida; Yasuko Kitagishi; Yuri Nishimura; Shio Iseki; Satoru Matsuda
Journal:  Lung Cancer Int       Date:  2012-02-01

9.  Inherited Rare, Deleterious Variants in ATM Increase Lung Adenocarcinoma Risk.

Authors:  Myvizhi Esai Selvan; Marjorie G Zauderer; Charles M Rudin; Siân Jones; Semanti Mukherjee; Kenneth Offit; Kenan Onel; Gad Rennert; Victor E Velculescu; Steven M Lipkin; Robert J Klein; Zeynep H Gümüş
Journal:  J Thorac Oncol       Date:  2020-08-28       Impact factor: 15.609

Review 10.  ATM rs189037 (G > A) polymorphism and risk of lung cancer and head and neck cancer: A meta-analysis.

Authors:  Aditi Bhowmik; Sayantan Nath; Sambuddha Das; Sankar Kumar Ghosh; Yashmin Choudhury
Journal:  Meta Gene       Date:  2015-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.